2-227082177-C-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000092.5(COL4A4):​c.1634G>C​(p.Gly545Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0318 in 1,613,770 control chromosomes in the GnomAD database, including 899 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G545V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.031 ( 84 hom., cov: 32)
Exomes 𝑓: 0.032 ( 815 hom. )

Consequence

COL4A4
NM_000092.5 missense

Scores

7
7
3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 4.08

Publications

31 publications found
Variant links:
Genes affected
COL4A4 (HGNC:2206): (collagen type IV alpha 4 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]
COL4A4 Gene-Disease associations (from GenCC):
  • autosomal recessive Alport syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Myriad Women’s Health, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Alport syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • hematuria, benign familial, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • autosomal dominant Alport syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 5 uncertain in NM_000092.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0072841644).
BP6
Variant 2-227082177-C-G is Benign according to our data. Variant chr2-227082177-C-G is described in ClinVar as Benign. ClinVar VariationId is 255015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0744 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000092.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
NM_000092.5
MANE Select
c.1634G>Cp.Gly545Ala
missense
Exon 23 of 48NP_000083.3P53420

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
ENST00000396625.5
TSL:5 MANE Select
c.1634G>Cp.Gly545Ala
missense
Exon 23 of 48ENSP00000379866.3P53420

Frequencies

GnomAD3 genomes
AF:
0.0308
AC:
4679
AN:
152136
Hom.:
84
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0342
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0264
Gnomad ASJ
AF:
0.0435
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00891
Gnomad FIN
AF:
0.0213
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0343
Gnomad OTH
AF:
0.0344
GnomAD2 exomes
AF:
0.0272
AC:
6788
AN:
249500
AF XY:
0.0271
show subpopulations
Gnomad AFR exome
AF:
0.0323
Gnomad AMR exome
AF:
0.0189
Gnomad ASJ exome
AF:
0.0431
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0226
Gnomad NFE exome
AF:
0.0375
Gnomad OTH exome
AF:
0.0370
GnomAD4 exome
AF:
0.0319
AC:
46619
AN:
1461516
Hom.:
815
Cov.:
31
AF XY:
0.0316
AC XY:
22982
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.0359
AC:
1203
AN:
33472
American (AMR)
AF:
0.0196
AC:
877
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0414
AC:
1081
AN:
26130
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.00822
AC:
709
AN:
86258
European-Finnish (FIN)
AF:
0.0215
AC:
1150
AN:
53416
Middle Eastern (MID)
AF:
0.0804
AC:
464
AN:
5768
European-Non Finnish (NFE)
AF:
0.0352
AC:
39119
AN:
1111664
Other (OTH)
AF:
0.0333
AC:
2013
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2211
4421
6632
8842
11053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1454
2908
4362
5816
7270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0307
AC:
4678
AN:
152254
Hom.:
84
Cov.:
32
AF XY:
0.0295
AC XY:
2198
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0342
AC:
1420
AN:
41534
American (AMR)
AF:
0.0263
AC:
403
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0435
AC:
151
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00891
AC:
43
AN:
4824
European-Finnish (FIN)
AF:
0.0213
AC:
226
AN:
10610
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0343
AC:
2330
AN:
68008
Other (OTH)
AF:
0.0341
AC:
72
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
237
474
710
947
1184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0344
Hom.:
80
Bravo
AF:
0.0315
TwinsUK
AF:
0.0410
AC:
152
ALSPAC
AF:
0.0319
AC:
123
ESP6500AA
AF:
0.0322
AC:
125
ESP6500EA
AF:
0.0358
AC:
296
ExAC
AF:
0.0282
AC:
3408
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0359
EpiControl
AF:
0.0407

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
Alport syndrome (2)
-
-
2
not provided (2)
-
-
1
Atypical hemolytic-uremic syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.090
T
BayesDel_noAF
Uncertain
0.13
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.66
D
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0073
T
MetaSVM
Uncertain
0.31
D
MutationAssessor
Pathogenic
3.9
H
PhyloP100
4.1
PrimateAI
Uncertain
0.57
T
PROVEAN
Pathogenic
-5.2
D
REVEL
Pathogenic
0.78
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.024
D
Polyphen
1.0
D
Vest4
0.32
MPC
0.64
ClinPred
0.085
T
GERP RS
5.3
Varity_R
0.85
gMVP
0.99
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800516; hg19: chr2-227946893; COSMIC: COSV61632129; API